BR112014017587A8 - métodos e formulações para o tratamento de deficiências de ácido siálico - Google Patents
métodos e formulações para o tratamento de deficiências de ácido siálicoInfo
- Publication number
- BR112014017587A8 BR112014017587A8 BR112014017587A BR112014017587A BR112014017587A8 BR 112014017587 A8 BR112014017587 A8 BR 112014017587A8 BR 112014017587 A BR112014017587 A BR 112014017587A BR 112014017587 A BR112014017587 A BR 112014017587A BR 112014017587 A8 BR112014017587 A8 BR 112014017587A8
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- sialic acid
- formulations
- treatment
- acid deficiencies
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 title abstract 3
- 230000007812 deficiency Effects 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 title abstract 3
- 238000013265 extended release Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261588069P | 2012-01-18 | 2012-01-18 | |
| US201261709549P | 2012-10-04 | 2012-10-04 | |
| PCT/US2013/022167 WO2013109906A2 (en) | 2012-01-18 | 2013-01-18 | Methods and formulations for treating sialic acid deficiencies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014017587A2 BR112014017587A2 (pt) | 2017-06-13 |
| BR112014017587A8 true BR112014017587A8 (pt) | 2017-07-04 |
Family
ID=48799814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014017587A BR112014017587A8 (pt) | 2012-01-18 | 2013-01-18 | métodos e formulações para o tratamento de deficiências de ácido siálico |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2804600A4 (enExample) |
| JP (2) | JP2015504094A (enExample) |
| KR (1) | KR20150000872A (enExample) |
| CN (1) | CN104271125A (enExample) |
| AU (1) | AU2013209610B2 (enExample) |
| BR (1) | BR112014017587A8 (enExample) |
| CA (1) | CA2862836A1 (enExample) |
| IL (1) | IL233225A0 (enExample) |
| WO (1) | WO2013109906A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9241896B2 (en) | 2008-12-19 | 2016-01-26 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
| KR20140003380A (ko) | 2010-07-13 | 2014-01-09 | 울트라제닉스 파마수티컬 인코포레이티드 | 시알산 결함 치료용 방법들 및 제형들 |
| HK1201067A1 (en) | 2011-10-24 | 2015-08-21 | 罕见病药物研发公司 | Sialic acid analogs |
| US10385085B2 (en) | 2015-09-14 | 2019-08-20 | Ultragenyx Pharmaceutical Inc. | Crystal forms of sialic acid or salt or solvate thereof |
| EP3486326A1 (en) | 2017-11-21 | 2019-05-22 | Jennewein Biotechnologie GmbH | Method for the purification of n-acetylneuraminic acid from a fermentation broth |
| CN117969774B (zh) * | 2024-04-02 | 2024-06-11 | 小仙炖霸州食品有限公司 | 一种自动化燕窝检测与分级系统 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3799874A1 (en) * | 2007-05-31 | 2021-04-07 | The Government of The United States of America, as represented by The Secretary, Department of Health and Human Services | N-acetyl mannosamine for the treatment of diabetes involving proteinuria |
| US20100159001A1 (en) * | 2008-12-19 | 2010-06-24 | Cardinal John R | Extended-Release Pharmaceutical Formulations |
| WO2010131712A1 (ja) * | 2009-05-15 | 2010-11-18 | 財団法人ヒューマンサイエンス振興財団 | Ｇｎｅタンパク質の機能低下に起因する疾患の治療用医薬剤、食品組成物、食品添加物 |
| KR20140003380A (ko) * | 2010-07-13 | 2014-01-09 | 울트라제닉스 파마수티컬 인코포레이티드 | 시알산 결함 치료용 방법들 및 제형들 |
| HK1201067A1 (en) * | 2011-10-24 | 2015-08-21 | 罕见病药物研发公司 | Sialic acid analogs |
-
2013
- 2013-01-18 BR BR112014017587A patent/BR112014017587A8/pt not_active Application Discontinuation
- 2013-01-18 CN CN201380015020.XA patent/CN104271125A/zh active Pending
- 2013-01-18 KR KR1020147022912A patent/KR20150000872A/ko not_active Withdrawn
- 2013-01-18 CA CA2862836A patent/CA2862836A1/en not_active Abandoned
- 2013-01-18 AU AU2013209610A patent/AU2013209610B2/en not_active Expired - Fee Related
- 2013-01-18 WO PCT/US2013/022167 patent/WO2013109906A2/en not_active Ceased
- 2013-01-18 JP JP2014553457A patent/JP2015504094A/ja active Pending
- 2013-01-18 EP EP13739040.7A patent/EP2804600A4/en not_active Withdrawn
-
2014
- 2014-06-18 IL IL233225A patent/IL233225A0/en unknown
-
2017
- 2017-07-21 JP JP2017141883A patent/JP2017186381A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015504094A (ja) | 2015-02-05 |
| AU2013209610A1 (en) | 2014-07-10 |
| CN104271125A (zh) | 2015-01-07 |
| EP2804600A2 (en) | 2014-11-26 |
| BR112014017587A2 (pt) | 2017-06-13 |
| AU2013209610B2 (en) | 2017-11-30 |
| KR20150000872A (ko) | 2015-01-05 |
| EP2804600A4 (en) | 2015-09-02 |
| WO2013109906A2 (en) | 2013-07-25 |
| JP2017186381A (ja) | 2017-10-12 |
| IL233225A0 (en) | 2014-08-31 |
| CA2862836A1 (en) | 2013-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013000776A2 (pt) | método e formulação para tratamento de deficiência de ácido siálico | |
| MX391043B (es) | Formulaciones de anticuerpo y metodos. | |
| DOP2014000233A (es) | Compuestos de microarn y métodos de modulación de la actividad de mir-21 | |
| BR112016012862A2 (pt) | formulações para vacinas para neoplasia | |
| CR20130480A (es) | Nuevos inmunoconjugados | |
| BR112015021999A2 (pt) | inibidores de indoleamina 2,3-dioxigenase (ido) | |
| CR20120413A (es) | Derivados de fumarato de ácido graso y sus usos | |
| CL2013001947A1 (es) | Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona. | |
| PT2852389T (pt) | Composições que compreendem benzodiazepinas de ação rápida | |
| GT201400101A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| CR20140554A (es) | Compuestos de acido dimetil-benzoico | |
| MX2020003096A (es) | Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif. | |
| BR112014014939A2 (pt) | composição de tratamento de sementes | |
| CR20140435A (es) | Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos | |
| EP2696874A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF NOSES | |
| BR112015002275A2 (pt) | processos e intermediários para a preparação de inibidores da integrase | |
| MX2015006337A (es) | Metodos y composiciones para tratar enfermedades neurodegenerativas. | |
| BR112014017587A2 (pt) | métodos e formulações para o tratamento de deficiências de ácido siálico | |
| GT201400242A (es) | "nuevos compuestos de pirazol" | |
| MX2015003701A (es) | Composiciones para tratamiento. | |
| BR112014026326A2 (pt) | composição para tratamento de distúrbios metabólicos | |
| MX2016006975A (es) | Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias. | |
| BR112017028448A2 (pt) | análogos de cisteamina resistentes a ado e usos dos mesmos | |
| ECSP13012366A (es) | Procedimiento de preparación de la sal de l-arginina de perindoprilo | |
| CO6801728A2 (es) | Formulación de lipomosas adecuada para tratar o prevenir la tuberculosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |